Moderna agrees to pay up to $2.25 billion to settle COVID vaccine patent dispute

Investing.com Gold reports: Moderna agrees to pay up to $2.25 billion to settle COVID vaccine patent dispute. This is a premium/paywalled source, so the brief is based on headline and available metadata only.